KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Other Operating Expenses (2019 - 2025)

Clover Health Investments' Other Operating Expenses history spans 7 years, with the latest figure at $470.9 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 53.82% year-over-year to $470.9 million; the TTM value through Dec 2025 reached $1.8 billion, up 44.76%, while the annual FY2025 figure was $1.8 billion, 44.76% up from the prior year.
  • Other Operating Expenses reached $470.9 million in Q4 2025 per CLOV's latest filing, roughly flat from $472.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $904.2 million in Q1 2022 to a low of -$1.5 billion in Q4 2022.
  • Average Other Operating Expenses over 5 years is $371.1 million, with a median of $378.5 million recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: soared 330.54% in 2021, then tumbled 367.91% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $563.6 million in 2021, then tumbled by 367.91% to -$1.5 billion in 2022, then skyrocketed by 122.04% to $332.8 million in 2023, then fell by 8.02% to $306.1 million in 2024, then surged by 53.82% to $470.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Other Operating Expenses are $470.9 million (Q4 2025), $472.1 million (Q3 2025), and $439.7 million (Q2 2025).